GHRH and GH secretagogues act at different pituitary receptor sites and their combination produces additive or supra-additive GH pulse amplitude responses
However, retatrutide remains investigational and is not FDA-approved or available by prescription outside of clinical trials
For questions about GLP-1 medications, speak with a health care provider
doi: 10.1111/j.1463-1326.2012.01557.x 159 AnvariMPatersonCADanielEEMcDonaldTJ
GLP-1s were originally developed to help manage Type 2 diabetes, but they are now commonly prescribed for weight loss
"One of the things that I realized the very first time I took a GLP-1 was that all these years I thought that thin people just had more willpower, they ate better foods, they were able to stick to it longer, they never had a potato chip, and then I realized the very first time I took the GLP-1 that, 'Oh, they're not even thinking about it